Our inability to detect CMV in baseline serum samples from CD4+ TEMhigh patients or liver biopsies from patients with high-grade hepatitis is a challenge for our theory; however, it may simply be beyond our technical capability to detect very low levels of compartmentalised viral reactivation. This evidence concerns the gene CD4 and hepatitis A virus infection.